These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15941929)

  • 1. Regulation of ghrelin secretion by somatostatin analogs in rats.
    Silva AP; Bethmann K; Raulf F; Schmid HA
    Eur J Endocrinol; 2005 Jun; 152(6):887-94. PubMed ID: 15941929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short- and long-term effects of octreotide and SOM230 on GH, IGF-I, ACTH, corticosterone and ghrelin in rats.
    Schmid HA; Silva AP
    J Endocrinol Invest; 2005; 28(11 Suppl International):28-35. PubMed ID: 16625842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5.
    Hofland LJ; van der Hoek J; Feelders R; van Aken MO; van Koetsveld PM; Waaijers M; Sprij-Mooij D; Bruns C; Weckbecker G; de Herder WW; Beckers A; Lamberts SW
    Eur J Endocrinol; 2005 Apr; 152(4):645-54. PubMed ID: 15817922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro.
    Hofland LJ; van der Hoek J; van Koetsveld PM; de Herder WW; Waaijers M; Sprij-Mooij D; Bruns C; Weckbecker G; Feelders R; van der Lely AJ; Beckers A; Lamberts SW
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1577-85. PubMed ID: 15070915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile.
    Bruns C; Lewis I; Briner U; Meno-Tetang G; Weckbecker G
    Eur J Endocrinol; 2002 May; 146(5):707-16. PubMed ID: 11980628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of somatostatin SST(2) receptor internalization in vivo after intravenous SOM230 application in the AR42J animal tumor model.
    Waser B; Cescato R; Tamma ML; Maecke HR; Reubi JC
    Eur J Pharmacol; 2010 Oct; 644(1-3):257-62. PubMed ID: 20643121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of endothelial proliferation by the somatostatin analogue SOM230.
    Adams RL; Adams IP; Lindow SW; Atkin SL
    Clin Endocrinol (Oxf); 2004 Oct; 61(4):431-6. PubMed ID: 15473874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin suppresses ghrelin secretion from the rat stomach.
    Shimada M; Date Y; Mondal MS; Toshinai K; Shimbara T; Fukunaga K; Murakami N; Miyazato M; Kangawa K; Yoshimatsu H; Matsuo H; Nakazato M
    Biochem Biophys Res Commun; 2003 Mar; 302(3):520-5. PubMed ID: 12615065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic-pharmacodynamic comparison of a novel multiligand somatostatin analog, SOM230, with octreotide in patients with acromegaly.
    Ma P; Wang Y; van der Hoek J; Nedelman J; Schran H; Tran LL; Lamberts SW
    Clin Pharmacol Ther; 2005 Jul; 78(1):69-80. PubMed ID: 16003295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severity of the catabolic condition differentially modulates hypothalamic expression of growth hormone-releasing hormone in the fasted mouse: potential role of neuropeptide Y and corticotropin-releasing hormone.
    Luque RM; Park S; Kineman RD
    Endocrinology; 2007 Jan; 148(1):300-9. PubMed ID: 17038558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric leptin, but not estrogen and somatostatin, contributes to the elevation of ghrelin mRNA expression level in fasted rats.
    Zhao Z; Sakata I; Okubo Y; Koike K; Kangawa K; Sakai T
    J Endocrinol; 2008 Mar; 196(3):529-38. PubMed ID: 18310448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of CRH-induced secretion of ACTH and corticosterone by SOM230 in rats.
    Silva AP; Schoeffter P; Weckbecker G; Bruns C; Schmid HA
    Eur J Endocrinol; 2005 Sep; 153(3):R7-R10. PubMed ID: 16131595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel molecular aspects of pituitary adenomas.
    Hubina E; Ruscica M; Nanzer AM; Czirják S; Góth MI; Grossman AB; Korbonits M
    J Endocrinol Invest; 2005; 28(11 Suppl International):87-92. PubMed ID: 16625855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pasireotide (SOM230) prevents sulfonylurea-induced hypoglycemia in rats.
    Schmid HA
    Exp Clin Endocrinol Diabetes; 2015 Mar; 123(3):193-7. PubMed ID: 25658662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single-dose comparison of the acute effects between the new somatostatin analog SOM230 and octreotide in acromegalic patients.
    van der Hoek J; de Herder WW; Feelders RA; van der Lely AJ; Uitterlinden P; Boerlin V; Bruns C; Poon KW; Lewis I; Weckbecker G; Krahnke T; Hofland LJ; Lamberts SW
    J Clin Endocrinol Metab; 2004 Feb; 89(2):638-45. PubMed ID: 14764775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The somatostatin analogue SOM230, compared with octreotide, induces differential effects in several metabolic pathways in acromegalic patients.
    van der Hoek J; van der Lelij AJ; Feelders RA; de Herder WW; Uitterlinden P; Poon KW; Boerlin V; Lewis I; Krahnke T; Hofland LJ; Lamberts SW
    Clin Endocrinol (Oxf); 2005 Aug; 63(2):176-84. PubMed ID: 16060911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ghrelin immunoreactivity in human plasma is suppressed by somatostatin.
    Nørrelund H; Hansen TK; Ørskov H; Hosoda H; Kojima M; Kangawa K; Weeke J; Møller N; Christiansen JS; Jørgensen JO
    Clin Endocrinol (Oxf); 2002 Oct; 57(4):539-46. PubMed ID: 12354137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pasireotide and octreotide stimulate distinct patterns of sst2A somatostatin receptor phosphorylation.
    Pöll F; Lehmann D; Illing S; Ginj M; Jacobs S; Lupp A; Stumm R; Schulz S
    Mol Endocrinol; 2010 Feb; 24(2):436-46. PubMed ID: 20051480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatin infusion lowers plasma ghrelin without reducing appetite in adults with Prader-Willi syndrome.
    Tan TM; Vanderpump M; Khoo B; Patterson M; Ghatei MA; Goldstone AP
    J Clin Endocrinol Metab; 2004 Aug; 89(8):4162-5. PubMed ID: 15292365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin receptor subtype expression in cells of the rat immune system during adjuvant arthritis.
    ten Bokum AM; Lichtenauer-Kaligis EG; Melief MJ; van Koetsveld PM; Bruns C; van Hagen PM; Hofland LJ; Lamberts SW; Hazenberg MP
    J Endocrinol; 1999 Apr; 161(1):167-75. PubMed ID: 10194540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.